Registry for people with CYP24A1 vitamin D–related kidney stone risk
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This is a research registry for people who have a confirmed CYP24A1 genetic change tied to high calcium and kidney stone problems. It helps researchers better understand who is affected and may guide future studies or care approaches.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had genetic testing that found a CYP24A1 mutation.
- Your results include at least three related health findings, like kidney stones, kidney calcium deposits, or bone problems.
- Blood/urine lab values fit the pattern seen in CYP24A1 deficiency (for example, calcium level high).
- Your vitamin D-related blood levels are high (or you have a close family member who meets the criteria).
- You have not had genetic testing that was negative for CYP24A1 if another condition explains your high calcium/stone risk.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information from people with certain inherited rare kidney stone conditions. It helps researchers learn about the conditions and supports future studies that may improve care.
This study uses genetic testing to look for inherited (“monogenic”) reasons some people get kidney stones. It may help explain the cause of stones and calcium-related problems, which can guide future care for you or your family.
This study collects and stores donated samples (like blood, urine, and tissue) from people with certain rare inherited kidney stone conditions. The goal is to build a resource for future research that could help improve diagnosis and treatment.
This study looks at whether having a specific gene change (CYP24A1) makes you more likely to develop kidney stones or calcium deposits in the kidneys. It includes both people with one copy of the changed gene and those with two copies.
This study looks at genes in people who form calcium phosphate kidney stones. It may help doctors understand why some people make this type of stone.
This study tests a vitamin D-like medicine for people with a specific genetic cause of low active vitamin D (CYP24A1 deficiency). If you have the right gene change, it may help your body use vitamin D more normally.
Hear when a new 24-hydroxylase Deficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.